BroadOak Fund

SeqWell’s is a biotechnology company that specializes in the fields of gene sequencing and laboratory services. It features a technology platform that serves as a transformative library prep technology that allows for simple, scalable multiplexing of 100s to 1000s of samples without time- and cost-consuming normalization. The company was founded in 2014 and headquartered in Massachusetts, United States.

Genomenon, Inc. is a biotechnology company that specializes in developing software tools for genetic diagnosis and research. Founded in 2014 and headquartered in Ann Arbor, Michigan, the company offers GENOMENON, a software solution designed for the rapid and automated analysis of next-generation sequencing data. This platform aids healthcare professionals and researchers by streamlining the identification of disease-causing variants from genomic datasets, thereby enhancing the accuracy and speed of genetic discoveries and diagnoses. Through its innovative tools, Genomenon aims to transform the landscape of genetic research and clinical decision-making.

PhenoVista Biosciences is a niche contract research organization (CRO) providing high content imaging-based phenotypic assay development and screening services. Using state-of-the-art technology, PhenoVista Biosciences performs phenotypic screen feasibility, development, and full-scale campaigns. PhenoVista Biosciences' team of cell biologists work closely with clients to get the data they need on time and on budget.

Accelix is a biotechnology company that helps cell and gene therapy companies to meet their key product QC requirements. It provides an instrument and a room temperature stable cartridge to gather multi-parameter results. The company was founded in 2007 and headquartered in Yerushalayim, Israel.

Gemini Bio-Products manufactures biological products and chemical reagents for the cell culture community globally. It offers cell culture sera, such as fetal bovine, specialized fetal bovine, other non-fetal, human and animal sera; custom and specialized media; and supplements and reagents, including amino acids, antibiotics and antimycotics, culture supplements and albumins, recombinant proteins, attachment factors, and cell dissociation reagents.

PBS Biotech, Inc, produces the easiest to use and most technologically-advanced bioreactors for the pharmaceutical industry. Their single-use bioreactors have the smallest per liter volume footprints and are fully scalable for any stage of the cell culture process, from R&D to clinical to cGMP production. They provide efficient, cost-effective disposable systems and top-notch technical services to help their customers solve complex cell culture challenges.

KromaTiD, Inc. is an early-stage bioscience company based in Fort Collins, Colorado, established in 2007. The company specializes in chromosome analysis products aimed at advancing the understanding of genetic abnormalities and diseases. KromaTiD develops molecular cytogenetic assays and reagents, including its proprietary Directional Genomic Hybridization (dGH) technology, which enhances standard fluorescence in situ hybridization (FISH) assays. These tools enable researchers to discover, detect, and diagnose various disease-causing mutations, such as inversions and translocations, from single cells. KromaTiD’s offerings include assays for targeting entire chromosomes or individual chromatids, inversion detection solutions, and custom assays covering the entire human genome. Their products are designed to support biomedical research and medical testing applications, facilitating advancements in oncology and rare diseases, and assisting research teams in academia and the biopharma sector in developing novel therapeutics.

Genomenon, Inc. is a biotechnology company that specializes in developing software tools for genetic diagnosis and research. Founded in 2014 and headquartered in Ann Arbor, Michigan, the company offers GENOMENON, a software solution designed for the rapid and automated analysis of next-generation sequencing data. This platform aids healthcare professionals and researchers by streamlining the identification of disease-causing variants from genomic datasets, thereby enhancing the accuracy and speed of genetic discoveries and diagnoses. Through its innovative tools, Genomenon aims to transform the landscape of genetic research and clinical decision-making.

Halo Labs (formerly Optofluidics) is a venture backed scientific instrumentation company that commercializes high throughput biopharmaceutical quality control tools using the latest optics, image processing and microfluidics. Our investors and development partners include BioAdvance, the National Science Foundation, the Defense Advanced Research Projects Agency, and the Ben Franklin Technology Partners. In 2012 Optofluidics was named Philadelphia Life Sciences startup of the year.

SeqWell’s is a biotechnology company that specializes in the fields of gene sequencing and laboratory services. It features a technology platform that serves as a transformative library prep technology that allows for simple, scalable multiplexing of 100s to 1000s of samples without time- and cost-consuming normalization. The company was founded in 2014 and headquartered in Massachusetts, United States.

InFuse Holdings operates high-quality, cost-effective ambulatory infusion centers. The infrastructure in the US for infusion therapies is lacking and, in most communities today, infusions centers have a wide range of cost and quality. InFuse Holdings brings best practices – in the workflow, inventory management, scheduling, safety protocols, staffing, customer experience, and outcomes data collection and reporting – to provide patients with a convenient, safe, and caring environment. The ambulatory infusion center model allows InFuse to provide these services at a lower cost than other delivery channels, helping to decrease the overall cost of healthcare for patients, employers, and payors.

SGI-DNA provides a variety of synthetic genomic solutions to advance your research. Our comprehensive suite of genomic services will allow you to discover, design, and build the sequences you need. We are committed to reducing barriers associated with DNA synthesis and sequence analysis by leveraging the technology developed at the J. Craig Venter Institute and Synthetic Genomics, Inc. SGI-DNA, a wholly owned subsidiary of Synthetic Genomics, Inc (SGI), was founded in 2013 and is headquartered in La Jolla, CA. Building on the scientific advancements and breakthroughs from leading scientists such as J. Craig Venter, Ham Smith, Clyde Hutchison, Dan Gibson and their teams, SGI-DNA utilizes unique and proprietary DNA technologies to produce complex synthetic genes and reagents. SGI-DNA also offers a comprehensive suite of genomic services, including whole genome sequencing, library design, and other bioinformatics services. SGI-DNA is responsible for all commercial aspects of SGI’s synthetic DNA business and focuses on strategic business relationships with both academic and commercial researchers.

BioInformatics, LLC is a market research and advisory firm that serves the life science, medical device, pharmaceutical, and diagnostic industries. The company specializes in both primary and secondary research, providing insights on market size, attractiveness, and product optimization. Key services include product concept testing, pricing strategy analysis, customer satisfaction assessments, and brand strength evaluations. BioInformatics helps clients navigate corporate acquisitions and measure brand loyalty, offering tailored research that informs strategic decisions. With a multidisciplinary team of industry veterans and research experts, the firm supports clients in enhancing their market positioning and developing effective marketing strategies. Founded in 1994 and based in Arlington, Virginia, BioInformatics caters to a diverse clientele, including biotechnology firms, medical diagnostics companies, and professional service providers.

MedCision is the world leader in next-generation automated cell thawing for advanced therapies. The company develops and commercializes technologies that automate and standardize vital preclinical and clinical biologics handling for critical post-manufacturing processes. MedCision’s digitally enabled ThawSTAR® Automated Cell Thawing Systems are designed to replace uncontrolled and highly variable manual methods, de-risking the therapeutic cell thawing process and optimizing cell efficacy. An industry first, ThawSTAR systems optimize cell thawing using a customizable algorithm for each unique cell therapy product and protocol. These systems, combined with MedCision’s ultra-low temperature cold storage and transport solutions, advance near-patient drug management by providing controlled and scalable processing of temperature-sensitive biotherapeutic products.

LabConnect, LLC offers comprehensive central laboratory services tailored for the biopharmaceutical industry. Founded in 2002 and headquartered in Johnson City, Tennessee, the company provides a wide range of services including routine testing in clinical chemistry, hematology, and infectious disease, as well as specialized testing in areas such as molecular diagnostics and oncology. LabConnect also offers pathology services, biostorage, sample tracking, and project management, alongside a Global Sample Processing Network that facilitates sample preparation and processing. Its BioVisualization software platform enables real-time analysis of clinical sample data. With additional laboratories located in California, Poland, India, Brazil, and Australia, LabConnect serves clients in drug development, medical devices, and contract research organizations, positioning itself as a single-source provider for laboratory service needs.

Empire leverages genomics technologies, its keen understanding of the medical system, the needs of clinicians to deliver precise and continuous testing expertise for the best in class oncology disease management tools. Empire is a leader in the field of molecular diagnostics services.

Rubicon Genomics was founded in 2000 by two University of Michigan faculty members, Dr. John Langmore and Dr. Vladimir Makarov, who wanted to advance the translation of human genetics “laboratory knowledge” into practical medicine applications. The founders also decided to maintain the company’s roots in Michigan with a commitment to supporting the Michigan economy. Today, Rubicon Genomics is a privately held company located in Ann Arbor, Michigan and employs 20 administrative and technical staff. Our innovative products combined with our strategic partnerships have established the company as a leader in pre-analytical amplification technologies that "break the sample barriers" for our customers. Rubicon sells its products into the research and commercial markets directly and through distributors

Diagnostic BioSystems Inc. specializes in enhancing immunohistochemistry results by offering innovative anatomic pathology reagents and systems. The company focuses on providing high-quality products and exceptional customer service. It serves the anatomic pathology and histology markets through direct sales in the domestic market and via international distributors in over 60 countries. Diagnostic BioSystems' product portfolio includes primary and FITC antibodies, autostainers, chromogens, detection kits, and various ancillary products, all designed to support the practice of pathology and improve diagnostic accuracy. Additionally, the company manufactures medical devices to complement its offerings.

BioCision’s mission is to standardize pre-analytical sample handling. They develop novel products that eliminate variability in common, often-overlooked, laboratory procedures. Their products are marketed globally and are widely used by the leading institutions in the biotech, pharmaceutical, clinical, diagnostic, academic and government scientific community. BioCision’s products include CoolRack®, CoolSink™ and ThermalTray™ laboratory tube and plate temperature standardizing modules, CoolBox™ ice-free benchtop coolers, CoolCell® alcohol-free cell freezing containers and TruCool™ accessories and consumables.